AIMEE ROBERTS-SERRATO: Open Payments
NPI 1659828994 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 74 payments from 16 companies in 2025. Trend: 2023 $1,524 · 2024 $1,701 · 2025 $2,038
Food & beverage: $2,038
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $499 |
| Axsome Therapeutics, Inc. | 4 | $315 |
| Vanda Pharmaceuticals Inc. | 12 | $283 |
| ABBVIE INC. | 10 | $186 |
| Lundbeck LLC | 6 | $141 |
| Alkermes, Inc. | 4 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| Neos Therapeutics, LP | 4 | $68 |
| Sage Therapeutics, LLC | 2 | $56 |
Products named: CAPLYTA, Auvelity, FANAPT, VRAYLAR, REXULTI, ARISTADA, TRINTELLIX, INGREZZA.
Industry payments across FL — which companies pay providers there.
